Product Information
APREPITANT 40 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $39.7598 per EA under NDC 00781232151. Its NADAC has been published 419 times since Jun 20, 2018.
Strength
40 mg/1
Manufacturer
Sandoz Inc.NDC
00781232151
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA090999On Market Since
12/27/2016
Pharmacological Classes
Price Statistics
The NADAC for APREPITANT 40 MG CAPSULE has been published 419 times since Jun 20, 2018, and over the history we have for it it has declined 47.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.7598 per EA |
|---|---|
| All-time high | $83.7756 (Aug 12, 2020) |
| All-time low | $34.4783 (Nov 20, 2024) |
| 52-week high | $50.0851 |
| 52-week low | $38.1856 |
| Median price | $66.7486 |
| Average price | $63.5922 |
| Largest weekly change | +42.7% (Feb 22, 2023) |
| Weeks tracked | 419 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APREPITANT 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 40 MG CAPSULE, manufactured by Sandoz Inc., is $39.7598 per EA (NDC 00781232151), effective Jun 24, 2026.
How has the price of APREPITANT 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APREPITANT 40 MG CAPSULE has declined 47.6%. It has been tracked across 419 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for APREPITANT 40 MG CAPSULE?
Since Jun 20, 2018, the NADAC for APREPITANT 40 MG CAPSULE has ranged from a low of $34.4783 (Nov 20, 2024) to a high of $83.7756 (Aug 12, 2020), with a median of $66.7486 per EA.
Are there cheaper alternatives to APREPITANT 40 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as APREPITANT 40 MG CAPSULE, but none are currently priced below it.
Who manufactures APREPITANT 40 MG CAPSULE?
APREPITANT 40 MG CAPSULE (NDC 00781232151) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification